![](https://news.europawire.eu/wp-content/uploads/2013/10/gsk.jpg)
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced it is divesting its meningitis vaccines Nimenrix and Mencevax to Pfizer Ireland Pharmaceuticals (a subsidiary of Pfizer Inc). LONDON, 24-6-2015 — /EuropaWire/ — The sale follows commitments given to the European Commission and other … Read the full press release